Advanced Search

 

Study ID Status Title Patient Level Data
114472 Completed A Placebo-Controlled, Four-Period Crossover, Single Ascending Oral Dose Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of the CCR9 Receptor Antagonist GSK1605786 in Japanese Healthy Male Subject
114479 Completed A Randomized, Double-Blind, Placebo-Controlled Multicenter Phase II Study to Evaluate the Safety and Efficacy and Dose Response of 28 Days of Once-Daily Dosing of the Oral Motilin Receptor Agonist GSK962040, in Type I and II Diabetic Male and Female Subjects with Gastroparesis
114482 Completed Demonstrating the clinical and economic benefit of 5 Alpha Reductase Inhibitor adherence in Benign Prostatic Hyperplasia
114490 Completed Phase I study of colistin methanesulfonate sodium (CMS-Na) -A randomized, double blind, placebo controlled, single and repeat dose study to investigate the safety, tolerability, and pharmacokinetics of CMS-Na in healthy Japanese male subjects -
114495 Completed An observer-blind safety and immunogenicity study of GSK Biologicals’ A/California/7/2009 (H1N1)v-like vaccines GSK2340274A and GSK2340272A in children 3 to less than 10 years old Study Listed on ClinicalStudyDataRequest.com
114496 Completed A randomised, double-blind, multi-centre study to evaluate the efficacy and safety of inhaled fluticasone furoate in the treatment of persistent asthma in adults and adolescents currently receiving mid to high strength inhaled corticosteroids. Study Listed on ClinicalStudyDataRequest.com
114500 Terminated LRRK2 Mutation and Parkinson’s Disease: A Functional Neuroimaging and Behavioural Study Characterising the Neurocognitive Phenotype
114520 Completed Effects of bronchodilatation with salmeterol on the autonomic nervous system
114522 Completed A nested case-control study of the association between Coreg IR and Coreg CR and hypersensitivity reactions: anaphylactic reaction/angioedema-Updated Analysis
114522_1 Completed A nested case-control study of the association between Coreg IR and Coreg CR and hypersensitivity reactions: anaphylactic reaction/angioedema-Updated Analysis
114527 Completed A Phase 1, open label, dose characteristic study to investigate the pharmacokinetics, pharmacodynamics, safety, and tolerability of intravenous and subcutaneous doses of GSK2315698A in patients with systemic amyloidosis
114535 Completed Blinded retrospective laboratory evaluations to assess the serologic response to Porcine circovirus type 1 (PCV-1) in the serum of infants aged 2 and 6 months and toddlers aged 4-6 years following administration of GlaxoSmithKline (GSK) Biologicals’ IPV-containing vaccines
114536 Completed An open-label study to evaluate the pharmacokinetics, safety and tolerability of repeat dosing lamotrigine in healthy Chinese subjects
114539 Completed PGx345: Pharmacogenetic investigation of the impact of functional N-acetyl transferase variants on reversible ALT elevations in healthy subjects following repeat dosing with GSK1322322
114541 Completed Efficacy study of GSK Biologicals’ quadrivalent influenza vaccine, GSK2282512A, (FLU Q-QIV) when administered in children Study Listed on ClinicalStudyDataRequest.com
114543 Completed A Multicentre, Randomized, Assessor-blind, Comparator-Controlled, Parallel-Group Clinical Trial to Establish the Efficacy and Safety of Duac™(1% clindamycin as clindamycin phosphate and 5% benzoyl peroxide) Once Daily Gel Compared with Clindamycin Phosphate gel (1% clindamycin as clindamycin phosphate) twice daily in the Treatment of Mild to Moderate Acne Vulgaris.
114544 Completed A single-blind, randomized, comparative pilot study evaluating the tolerability of two topical combination therapies in the treatment of acne vulgaris Study Listed on ClinicalStudyDataRequest.com
114545 Completed Two-week Study to Determine and Compare the Tolerance and Irritation Potential of Clindamycin and Benzoyl Peroxide to Dapsone Gel Topical Acne Medications
114546 Completed Two-week Study to Determine and Compare the Tolerance and Irritation Potential of Duac® Topical Gel (clindamycin 1% and benzoyl peroxide 5%) to ACANYA™ Gel (clindamycin phosphate 1.2% and benzoyl peroxide 2.5%) Topical Acne Medications Study Listed on ClinicalStudyDataRequest.com
114547 Completed A single-blind, randomized, comparative split-face study evaluating the tolerability of clindamycin and benzoyl peroxide gel to benzoyl peroxide/adapalene gel in the treatment of acne vulgaris. Study Listed on ClinicalStudyDataRequest.com
114550 Completed U0289-401: An Evaluator Blinded, 8 Week, Split-Face Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and PROACTIV in Subjects with Acne Study Listed on ClinicalStudyDataRequest.com
114551 Completed U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects with Acne Study Listed on ClinicalStudyDataRequest.com
114552 Completed An open label, randomised, repeat dose study to assess the pharmacokinetic performance of five ezogabine/retigabine modified release (MR) formulations at steady state compared to the immediate release (IR) formulation. Study Listed on ClinicalStudyDataRequest.com
114553 Completed U0289-404: An Evaluator Blinded, 8 Week, Split Face Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITYII and MURAD in Subjects with Acne Study Listed on ClinicalStudyDataRequest.com
114554 Completed A phase 2, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in subjects with distal subungual onychomycosis

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.